News:

09/23/2021 ClearNano Inc. received a Fast-Track Small Business Innovation Research (SBIR) grant from NIH NCI to develop a fluorescent imaging agent for fluorescence-guided kidney cancer surgery.

09/24/2021 ClearNano Inc. received a Phase II Small Business Technology Transfer (STTR) grant from NIH NIDDK to further develop a test agent for early detection of lupus nephritis towards clinical translation.

09/19/2019 ClearNano Inc. received a Phase I Small Business Technology Transfer (STTR) grant from NIH NIDDK to develop a test agent for early detection of lupus nephritis.

09/10/2018 ClearNano Inc. received an Administrative Supplement grant from NIH NIDDK to attend Concept to Clinic: Commercializing Innovation (C3i) Program.

09/18/2017 ClearNano Inc. received a Phase I Small Business Innovation Research (SBIR) grant from NIH NIDDK to develop a fluorescent imaging agent for early detection of drug-induced kidney injuries in the preclinical settings.